E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/13/2011 in the Prospect News High Yield Daily.

S&P still may lift Nycomed

Standard & Poor's said it is keeping the B+ long-term corporate credit rating on Nycomed SCA Sicar on CreditWatch positive, where it was placed on May 20.

The update reflects the acquisition of Nycomed A/S by Takeda Pharmaceutical Co. Ltd. (AA/Watch negative/A-1+) for €9.6 billion, the agency said.

In addition, the watch now reflects that on the close of the acquisition, Nycomed will repay its outstanding senior secured debt of about €4 billion in full using the proceeds from the disposal of Nycomed A/S, the agency noted.

The rating reflects the company's aggressive financial risk profile, with a track record of using debt as the primary source of financing acquisitions, S&P said.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.